CERENOME Trademark

Serial Number: 99834767

CERENOME is a trademark filed by Plus Therapeutics, Inc. on May 20, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Trademark Classes

5

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

44

Class 44 - Medical Services

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Owner Contact Info

Plus Therapeutics, Inc.

2710 Reed Rd, Suite 160
Houston, TX 77051

Entity Type: 03

Legal Representation

Attorney of Record

PAOLO ANTONIO STRINO

40 trademarks filed View all →

Correspondence Address

PAOLO ANTONIO STRINO FBT Gibbons

One Pennsylvania Plaza

New York, NY 10119

United States

Trademark Details

Filing Date

May 20, 2026

Registration Date

Not Registered

Goods & Services

Medical diagnostic testing services in the field of oncology and diseases of the central nervous system; providing medical information in the field of cancer diagnosis and treatment; providing medical information services in the field of oncology and central nervous system diseases and disorders, including through data analytics; providing healthcare data analytics services, namely, analysis of clinical and medical data in the fields of oncology and diseases and disorders of the central nervous system.

Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system; radiopharmaceutical preparations for diagnostic and therapeutic purposes; diagnostic preparations for medical purposes for the detection and characterization of cancer and other diseases, including diseases and disorders of the central nervous system.

Medical research in the field of oncology; medical research laboratory services in the field of oncology; pharmaceutical research and development services; providing medical and scientific information in the field of cancer, diseases and disorders of the central nervous system, and oncological diseases and disorders; data analytics services in the field of oncology and central nervous system diseases and disorders; software as a service (SAAS) services featuring software for data analytics in the fields of pharmaceutical research, oncology, and diseases and disorders of the central nervous system; providing scientific and research information in the field of oncology and central nervous system diseases and disorders via a website.